Regulus Therapeutics
RGLS
#6970
Rank
S$0.72 B
Marketcap
S$10.51
Share price
0.00%
Change (1 day)
410.35%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: S$0.72 Billion

As of December 2025 Regulus Therapeutics has a market cap of S$0.72 Billion. This makes Regulus Therapeutics the world's 6970th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.72 B430.91%
2024S$0.13 B301.07%
2023S$34.18 M10.53%
2022S$30.92 M-50.24%
2021S$62.16 M-45.19%
2020S$0.11 B349.71%
2019S$25.21 M124.96%
2018S$11.21 M-92.25%
2017S$0.14 B-16.1%
2016S$0.17 B-73.47%
2015S$0.64 B-37.37%
2014S$1.03 B165.13%
2013S$0.39 B41.73%
2012S$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
S$126.73 B 17,310.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
S$150.77 B 20,612.82%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$33.06 B 4,441.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$365.90 B 50,166.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
S$69.47 B 9,444.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.20 B-72.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$143.58 B 19,625.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.83 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA